Jason Chew
Jason Chew
Send Message
Jason Chew
Stop FollowingJason Chew
ABOUT
My goal is to share some of the insights I have gained over the years with fellow investors.
Join me at www.ChimeraResearchGroup.com
Follow me at twitter.com/nexparadigm
As I am neither licensed nor qualified to act as an investment advisor, my articles are written for discussion purposes only and should not be construed as investment advice. I make a reasonable effort to avoid misstatements of fact, but advise all investors to consult primary sources prior to making an investment decision.
Join me at www.ChimeraResearchGroup.com
Follow me at twitter.com/nexparadigm
As I am neither licensed nor qualified to act as an investment advisor, my articles are written for discussion purposes only and should not be construed as investment advice. I make a reasonable effort to avoid misstatements of fact, but advise all investors to consult primary sources prior to making an investment decision.
SNAPSHOT
- Description: Newsletter author. Trading frequency: Not Trading
- Interests: Options, Stocks - long, Stocks - short
COMPANY
Chimera Research Group Our Mission is to give each subscriber, retail or institutional, the most valuable insights and strategies in the biopharmaceutical sector. We strive to provide our subscribers with actionable market intelligence by leveraging the experience, accomplishments and intellectual horsepower of our founding ...More
members.
We aim to:
•Offer unprecedented medical, scientific and statistical analysis.
•Utilize innovative long & short stock and option strategies to maximize the risk reward profile.
•Enable subscribers to navigate all upcoming industry catalysts through our proprietary database and calendars.
•Provide our subscribers with a comprehensive view of the entire biotech and pharmaceutical sectors.
•Provide our subscribers with interactive events and direct communication.
Subscribe to Chimera Research Group and proceed with confidence!
BLOG
Book
Currently, there are no book details for Jason Chew.
Latest Comments
more »
- It is not, aside from a pea... on Ariad: Shares Overvalued On Fundamentals
- sure- if you think manageme... on Celsion Dilutes By Fifty Percent
- disagree. w/ generic spryce... on Ariad: Shares Overvalued On Fundamentals
- Since someone finally put u... on Celsion's HEAT Study: A Far From Certain Outcom...
- Great job! Unfortunately, n... on Celsion's HEAT Study: A Far From Certain Outcom...
Latest comments on Jason's Articles
LATEST ARTICLES & INSTAPOSTS
more »


